Who will fund hypothesis testing studies?
EDITOR—Although Loke et al concluded that case reports in pharmacovigilance have limited value, 1 case reports or series are valuable as hypothesis generating papers, which benefit clinicians and patients. The number of follow-up studies is only one outcome by which to judge the value of case reports or series, but other outcomes may be more difficult to study.
